Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort

Cancer Causes and Control

Volumn 23, Issue 8, 2012, Pages 1307-1316

  Markkula, Andrea ^a   Bromée, Anna ^a   Henningson, Maria ^b   Hietala, Maria ^a   Hietala, Anita ^a,c   Ingvar, Christian ^a   Rose, Carsten ^d   Jernström, Helena ^a  

^a LUND UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c VRINNEVI HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body mass index; Breast cancer; Breast size; Prognosis; Waist to hip ratio

Indexed keywords

ADULT; AGE; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; AXILLARY LYMPH NODE; BODY MASS; BREAST CANCER; BREAST SIZE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL TIME; SWEDEN; TUMOR VOLUME; WAIST HIP RATIO;

ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; SWEDEN; WAIST-HIP RATIO;

EID: 84864886618     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0008-9     Document Type: Article

References (51)

1. The National Board of Health and Welfare (2010) Cancer incidence in Sweden (Cited May 30, 2012) http://www.socialstyrelsen.se/Lists/Artikelkatalog/ Attachments/18530/2011-12-15.pdf
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2008) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon
3. Han D, Nie J, Bonner MR et al (2006) Lifetime adult weight gain, central adiposity, and the risk of pre-and postmenopausal breast cancer in the Western New York exposures and breast cancer study. Int J Cancer 119:2931-2937
4. Carmichael AR (2006) Obesity and prognosis of breast cancer. Obes Rev 7:333-340
5. Carmichael AR, Bates T (2004) Obesity and breast cancer: a review of the literature. Breast 13:85-92
6. Loi S, Milne RL, Friedlander ML et al (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1686-1691
7. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627-635
8. Petrelli JM, Calle EE, Rodriguez C, Thun MJ (2002) Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 13: 325-332
9. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L (2000) Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 9:681-687
10. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis. Int J Cancer 124: 698-712
11. Pinheiro RL, Sarian LO, Pinto-Neto AM, Morais S, Costa-Paiva L (2009) Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre-and postmenopausal women. Breast 18:8-12
12. Healy LA, Ryan AM, Carroll P et al (2010) Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol) 22:281-288
13. Baumgartner KB, Hunt WC, Baumgartner RN et al (2004) Association of body composition and weight history with breast cancer prognostic markers: divergent pattern for Hispanic and non-Hispanic White women. Am J Epidemiol 160:1087-1097
14. Harvie M, Hooper L, Howell AH (2003) Central obesity and breast cancer risk: a systematic review. Obes Rev 4:157-173
15. Borugian MJ, Sheps SB, Kim-Sing C et al (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158:963-968
16. Jernström H, Barrett-Connor E (1999) Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study. J Womens Health Gend Based Med 8: 1265-1272
17. Björntorp P (1997) Hormonal control of regional fat distribution. Hum Reprod 12(Suppl 1):21-25
18. Hollmann M, Runnebaum B, Gerhard I (1997) Impact of waisthip-ratio and body-mass-index on hormonal and metabolic parameters in young, obese women. Int J Obes Relat Metab Disord 21:476-483
19. Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42-51
20. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ (1992) Insulin resistance and breastcancer risk. Int J Cancer 52:511-516
21. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ (1998) Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-120
22. Sellahewa C, Nightingale P, Carmichael AR (2008) Women with large breasts are at an increased risk of advanced breast cancer. Int Semin Surg Oncol 5:16
23. Hsieh CC, Trichopoulos D (1991) Breast size, handedness and breast cancer risk. Eur J Cancer 27:131-135
24. Hall HI, Coates RJ, Uhler RJ et al (1999) Stage of breast cancer in relation to body mass index and bra cup size. Int J Cancer 82:23-27
25. Ingram DM, Huang HY, Catchpole BN, Roberts A (1989) Do big breasts disadvantage women with breast cancer? Aust N Z J Surg 59:115-117
26. Hoe AL, Mullee MA, Royle GT, Guyer PB, Taylor I (1993) Breast size and prognosis in early breast cancer. Ann R Coll Surg Engl 75:18-22
27. Sung J, Song YM, Stone J, Lee K, Kim SY (2010) Association of body size measurements and mammographic density in Koreanwomen: the Healthy Twin study. Cancer Epidemiol Biomarkers Prev 19:1523-1531
28. Wade TD, Zhu G, Martin NG (2010) Body mass index and breast size in women: same or different genes? Twin Res Hum Genet 13:450-454
29. Jernström H, Olsson H (1997) Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19-25 years. Am J Epidemiol 145:571-580
30. Ray JG, Mohllajee AP, van Dam RM, Michels KB (2008) Breast size and risk of type 2 diabetes mellitus. CMAJ 178:289-295
31. Schrauder MG, Fasching PA, Haberle L et al (2011) Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol 137:975-983
32. Kusano AS, Trichopoulos D, Terry KL, Chen WY, Willett WC, Michels KB (2006) A prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer 118:2031-2034
33. Ringberg A, Bågeman E, Rose C, Ingvar C, Jernström H (2006) Of cup and bra size: reply to a prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer 119: 2242-2243; Author reply 4
34. Strombeck JO, Malm M (1986) Priority grouping in a waiting list of patients for reduction mammaplasty. Ann Plast Surg 17:498-502
35. -(2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series. 894:i-xii, 1-253
36. Bågeman E, Ingvar C, Rose C, Jernström H (2008) Coffee consumption and CYP1A21F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev 17:895-901
37. Jernström H, Sandberg T, Bågeman E, Borg A ̊ , Olsson H (2005) Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Br J Cancer 92:857-866
38. Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915-928
39. Hankinson SE, Willett WC, Colditz GA et al (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
40. Gee JM, Robertson JF, Gutteridge E et al (2005) Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr Relat Cancer 12(Suppl 1):S99-S111
41. Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulinlike growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530-542
42. Hartmann BW, Laml T, Kirchengast S, Albrecht AE, Huber JC (1998) Hormonal breast augmentation: prognostic relevance of insulin-like growth factor-I. Gynecol Endocrinol 12:123-127
43. Diorio C, Pollak M, Byrne C et al (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14:1065-1073
44. Chiu SY, Duffy S, Yen AM, Tabar L, Smith RA, Chen HH (2010) Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 19:1219-1228
45. Heidegger I, Pircher A, Klocker H, Massoner P (2011) Targeting the insulin-like growth factor network in cancer therapy. Cancer Biol Ther 11:701-707
46. Mayes JS, Watson GH (2004) Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 5:197-216
47. Lundin KB, Henningson M, Hietala M, Ingvar C, Rose C, Jernstro ̈m H (2011) Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients. Br J Cancer 105:1676-1683
48. van Anders SM, Hampson E (2005) Waist-to-hip ratio is positively associated with bioavailable testosterone but negatively associated with sexual desire in healthy premenopausal women. Psychosom Med 67:246-250
49. Peiris AN, Struve MF, Kissebah AH (1987) Relationship of body fat distribution to the metabolic clearance of insulin in premenopausal women. Int J Obes 11:581-589
50. Subbaramaiah K, Howe LR, Bhardwaj P et al (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res 4:329-346
51. Goodwin PJ, Stambolic V, Lemieux J et al (2011) Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat 126:215-220